Morgan Stanley Emergent Bio Solutions Inc. Transaction History
Morgan Stanley
- $1.27 Trillion
- Q2 2024
A detailed history of Morgan Stanley transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Morgan Stanley holds 1,242,137 shares of EBS stock, worth $11.6 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,242,137
Previous 1,293,702
3.99%
Holding current value
$11.6 Million
Previous $3.27 Million
158.81%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding EBS
# of Institutions
149Shares Held
30.6MCall Options Held
137KPut Options Held
706K-
Black Rock Inc. New York, NY3.84MShares$35.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.67MShares$34.2 Million0.0% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA3.17MShares$29.5 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny946KShares$8.83 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA897KShares$8.37 Million0.0% of portfolio
About Emergent BioSolutions Inc.
- Ticker EBS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,861,500
- Market Cap $465M
- Description
- Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...